Biotechnology Industry Overview
The Biotechnology industry involves the use of living organisms, cells or biological processes to develop and manufacture new products that improve healthcare, agriculture, and industry. It includes genetically modified crop production, new drug development, and advanced diagnostics. Many biotech products are the result of genetic engineering, using cutting-edge technology to manipulate DNA to create new products, such as synthetic insulin or cancer-fighting drugs.
Public Companies in this Industry
Ticker | Company | Market Cap | Country |
---|---|---|---|
068270 | Celltrion Inc | $22t | Korea |
NOVO-B | Novo Nordisk A/S | $2t | Denmark |
4974 | Takara Bio Inc | $208b | Japan |
603392 | Beijing Wantai Biological Pharmacy Enterprise Co Ltd | $107b | China |
VRTX | Vertex Pharmaceuticals Inc | $103b | USA |
REGN | Regeneron Pharmaceuticals Inc | $97b | USA |
300759 | Pharmaron Beijing Co Ltd | $55b | China |
002821 | Asymchem Laboratories Tian Jin Co Ltd | $52b | China |
300957 | Yunnan Botanee Bio-Technology Group Co Ltd | $52b | China |
002252 | Shanghai RAAS Blood Products Co Ltd Class A | $45b | China |
002007 | Hualan Biological EngineeringInc | $45b | China |
SGEN | Seagen Inc | $43b | USA |
MRNA | Moderna Inc | $42b | USA |
1548 | Genscript Biotech Corp | $42b | Hong Kong |
688180 | Shanghai Junshi Biosciences Co Ltd | $41b | China |
603233 | Dashenlin Pharm Grp Co Ltd | $35b | China |
BNTX | BioNTech SE | $21b | USA |
ARGX | argenx NV ADR | $21b | USA |
GMAB | Genmab AS | $18.58b | USA |
ALNY | Alnylam Pharmaceuticals Inc | $17.85b | USA |
BMRN | Biomarin Pharmaceutical Inc | $17.01b | USA |
BGNE | BeiGene Ltd | $15.04b | USA |
UCB | UCB SA | $15.04b | Belgium |
RPRX | Royalty Pharma plc | $12.02b | USA |
INCY | Incyte Corporation | $11.54b | USA |
KRTX | Karuna Therapeutics Inc | $11.38b | USA |
UTHR | United Therapeutics Corporation | $10.97b | USA |
SRPT | Sarepta Therapeutics Inc | $10.93b | USA |
TECH | Bio-Techne Corp | $9.99b | USA |
RXDX | Prometheus Biosciences Inc | $9.50b | USA |
ASND | Ascendis Pharma AS | $8.18b | USA |
EXEL | Exelixis Inc | $7.68b | USA |
LEGN | Legend Biotech Corp | $7.56b | USA |
ROIV | Roivant Sciences Ltd. Common Shares | $7.54b | USA |
IMGN | ImmunoGen Inc | $7.06b | USA |
JAZZ | Jazz Pharmaceuticals plc | $6.66b | USA |
CERE | Cerevel Therapeutics Holdings Inc | $6.56b | USA |
CYTK | Cytokinetics Inc | $6.36b | USA |
IONS | Ionis Pharmaceuticals Inc | $6.07b | USA |
APLS | Apellis Pharmaceuticals Inc | $5.56b | USA |
BPMC | Blueprint Medicines Corp | $5.53b | USA |
RETA | Reata Pharmaceuticals Inc | $5.53b | USA |
ISEE | IVERIC bio Inc | $5.48b | USA |
HALO | Halozyme Therapeutics Inc | $5.30b | USA |
VKTX | Viking Therapeutics Inc | $5.10b | USA |
PCVX | Vaxcyte Inc | $4.83b | USA |
CRBP | Corbus Pharmaceuticals Holdings, Inc | $4.44b | USA |
CRSP | Crispr Therapeutics AG | $4.38b | USA |
KRYS | Krystal Biotech Inc | $4.10b | USA |
BBIO | BridgeBio Pharma Inc | $4.01b | USA |
RVMD | Revolution Medicines Inc | $3.78b | USA |
IMVT | Immunovant Inc | $3.75b | USA |
MDGL | Madrigal Pharmaceuticals Inc | $3.71b | USA |
NK | NantKwest Inc | $3.71b | USA |
MNMD | Mind Medicine (MindMed) Inc | $3.56b | USA |
INSM | Insmed Inc | $3.52b | USA |
NUVL | Nuvalent Inc | $3.43b | USA |
MRTX | Mirati Ther | $3.41b | USA |
HCM | HUTCHMED (China) Limited | $3.18b | USA |
CBAY | Cymabay Therapeu | $3.16b | USA |
RARE | Ultragenyx | $3.11b | USA |
AXSM | Axsome Therapeutics Inc | $3.10b | USA |
FOLD | Amicus Therapeutics Inc | $2.98b | USA |
ALPN | Alpine Immune Sciences Inc | $2.96b | USA |
IMCR | Immunocore Holdings Ltd | $2.81b | USA |
SWTX | SpringWorks Therapeutics Inc | $2.71b | USA |
ACAD | ACADIA Pharmaceuticals Inc | $2.69b | USA |
KDNY | Chinook Therapeutics Inc | $2.66b | USA |
INO | Inovio Pharmaceuticals Inc | $2.64b | USA |
IOVA | Iovance Biotherapeutics Inc | $2.63b | USA |
BHVN | Biohaven Pharmaceutical Holding Company Ltd | $2.54b | USA |
ARWR | Arrowhead Pharmaceuticals Inc | $2.52b | USA |
SMMT | Summit Therapeutics PLC | $2.50b | USA |
ACLX | Arcellx Inc | $2.50b | USA |
XENE | Xenon Pharmaceuticals Inc | $2.49b | USA |
MOR | MorphoSys AG | $2.46b | USA |
CORT | Corcept Therapeutics Incorporated | $2.43b | USA |
CRNX | Crinetics Pharmaceuticals Inc | $2.34b | USA |
PRAX | Praxis Precision Medicines Inc | $2.29b | USA |
PRVB | Provention Bio Inc | $2.28b | USA |
DICE | Dice Molecules Holdings LLC | $2.27b | USA |
AGEN | Agenus Inc | $2.26b | USA |
RYTM | Rhythm Pharmaceuticals Inc | $2.25b | USA |
VCEL | Vericel Corp Ord | $2.18b | USA |
DNLI | Denali Therapeutics Inc | $2.13b | USA |
IBRX | Immunitybio Inc | $2.10b | USA |
TGTX | TG Therapeutics Inc | $2.05b | USA |
JANX | Janux Therapeutics Inc. Common Stock | $2.01b | USA |
MRUS | Merus BV | $1.94b | USA |
KYMR | Kymera Therapeutics Inc | $1.94b | USA |
IDYA | Ideaya Biosciences Inc | $1.93b | USA |
GLPG | Galapagos NV ADR | $1.90b | USA |
RCKT | Rocket Pharmaceuticals Inc | $1.87b | USA |
BLU | BELLUS Health Inc. | $1.87b | USA |
NTLA | Intellia Therapeutics Inc | $1.86b | USA |
PTCT | PTC Therapeutics Inc | $1.86b | USA |
OTLK | Outlook Therapeutics Inc | $1.84b | USA |
RNA | Avidity Biosciences Inc | $1.78b | USA |
AGIO | Agios Pharm | $1.75b | USA |
CLDX | Celldex Therapeutics Inc | $1.75b | USA |